Secondly, given the cross-sectional nature and complexity of CKD-MBD in our study, it is difficult to clarify whether the association between PTH and sarcopenia results from the direct detrimental effect of PTH on sarcopenia or from other CKD-MBD biomarkers influencing serum PTH levels. This evidence concerns the gene PTH and chronic kidney disease.